Karuna Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Karuna Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 94% to $654,000. Profit margin reached -66312%. Total operating expenses were $495,431,000.
Profit Margin
| 2017 | 0 | -6.03M | |
|---|---|---|---|
| 2018 | 0 | -17.51M | |
| 2019 | 0 | -44.84M | |
| 2020 | 0 | -68.55M | |
| 2021 | 36.96M | -143.80M | -389.04% |
| 2022 | 10.63M | -276.33M | -2597.88% |
| 2023 | 654K | -433.68M | -66311.93% |
KRTX Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 654K | 10.63M | 36.96M | 0 | 0 | 0 | 0 |
Cost of revenue | 1.70M | 1.11M | 506K | 145K | 58K | 0 | 0 |
Gross profit | -1.04M | 9.52M | 36.45M | -145K | -58K | 0 | 0 |
Operating exp. | |||||||
Research and development | 364.10M | 224.24M | 128.2M | 43.40M | 24.53M | 11.53M | 3.61M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 495.43M | 300.31M | 180.81M | 71.81M | 45.40M | 14.51M | 4.80M |
Operating income | -494.77M | -289.67M | -143.85M | -71.81M | -45.40M | -14.51M | -4.80M |
Other income (expenses), net | 61.76M | 14.75M | 54K | 3.30M | 1.44M | -444K | -1.22M |
Income before tax | -433.01M | -274.91M | -143.79M | -68.51M | -43.95M | -17.51M | -6.03M |
Income tax expense | 670K | 1.41M | 6K | 43K | 887K | -419K | 1.17M |
Net income | -433.68M | -276.33M | -143.80M | -68.55M | -44.84M | -17.51M | -6.03M |
Earnings per share | |||||||
Basic EPS | -11.73 | -8.74 | -4.94 | -2.59 | -3.75 | -1.61 | -0.81 |
Diluted EPS | -11.73 | -8.74 | -4.94 | -2.59 | -3.75 | -1.61 | -0.81 |
| Data source | Data source | Data source | Data source | Data source |